unknown
Stage
1
Investors
About
Celea Therapeutics develops treatments aimed at liver diseases with a focus on fibrotic and metabolic liver conditions.
Explore Celea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.